These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39355913)

  • 21. Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: a Mendelian randomization study.
    Nazarzadeh M; Pinho-Gomes AC; Bidel Z; Canoy D; Dehghan A; Smith Byrne K; Bennett DA; Smith GD; Rahimi K
    Genome Med; 2021 Mar; 13(1):38. PubMed ID: 33663581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the causal relationships and mediating factors between depression, anxiety, panic, and atrial fibrillation: A multivariable Mendelian randomization study.
    Zhou H; Ji Y; Sun L; Wang Z; Jin S; Wang S; Yang C; Yin D; Li J
    J Affect Disord; 2024 Mar; 349():635-645. PubMed ID: 38211754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.
    Khurshid S; Friedman S; Reeder C; Di Achille P; Diamant N; Singh P; Harrington LX; Wang X; Al-Alusi MA; Sarma G; Foulkes AS; Ellinor PT; Anderson CD; Ho JE; Philippakis AA; Batra P; Lubitz SA
    Circulation; 2022 Jan; 145(2):122-133. PubMed ID: 34743566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low remnant cholesterol and the subsequent risk of new-onset atrial fibrillation: A prospective cohort study.
    Chen ZT; Guo DC; Gao JW; Gao QY; Zhang YP; He WB; Wu MX; Liu PM; Wang JF; Zhang HF; Chen YX
    Heart Rhythm; 2024 Aug; 21(8):1258-1266. PubMed ID: 38815780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study.
    Tancin Lambert A; Kong XY; Ratajczak-Tretel B; Atar D; Russell D; Skjelland M; Bjerkeli V; Skagen K; Coq M; Schordan E; Firat H; Halvorsen B; Aamodt AH
    Cerebrovasc Dis Extra; 2020; 10(1):11-20. PubMed ID: 32028277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart rate variability and atrial fibrillation in the general population: a longitudinal and Mendelian randomization study.
    Geurts S; Tilly MJ; Arshi B; Stricker BHC; Kors JA; Deckers JW; de Groot NMS; Ikram MA; Kavousi M
    Clin Res Cardiol; 2023 Jun; 112(6):747-758. PubMed ID: 35962833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated Lipoprotein(a) and Risk of Atrial Fibrillation: An Observational and Mendelian Randomization Study.
    Mohammadi-Shemirani P; Chong M; Narula S; Perrot N; Conen D; Roberts JD; Thériault S; Bossé Y; Lanktree MB; Pigeyre M; Paré G
    J Am Coll Cardiol; 2022 Apr; 79(16):1579-1590. PubMed ID: 35450575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the causal association of rheumatoid arthritis with atrial fibrillation: a Mendelian randomization study.
    Rong JC; Chen XD; Jin NK; Hong J
    Clin Rheumatol; 2024 Jan; 43(1):29-40. PubMed ID: 37930596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
    Hyman MC; Levin MG; Gill D; Walker VM; Georgakis MK; Davies NM; Marchlinski FE; Damrauer SM
    Hypertension; 2021 Feb; 77(2):376-382. PubMed ID: 33390040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the Relationship Between Genetic Determinants of Thyroid Function and Atrial Fibrillation: A Mendelian Randomization Study.
    Ellervik C; Roselli C; Christophersen IE; Alonso A; Pietzner M; Sitlani CM; Trompet S; Arking DE; Geelhoed B; Guo X; Kleber ME; Lin HJ; Lin H; MacFarlane P; Selvin E; Shaffer C; Smith AV; Verweij N; Weiss S; Cappola AR; Dörr M; Gudnason V; Heckbert S; Mooijaart S; März W; Psaty BM; Ridker PM; Roden D; Stott DJ; Völzke H; Benjamin EJ; Delgado G; Ellinor P; Homuth G; Köttgen A; Jukema JW; Lubitz SA; Mora S; Rienstra M; Rotter JI; Shoemaker MB; Sotoodehnia N; Taylor KD; van der Harst P; Albert CM; Chasman DI
    JAMA Cardiol; 2019 Feb; 4(2):144-152. PubMed ID: 30673084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.
    Yao P; Iona A; Pozarickij A; Said S; Wright N; Lin K; Millwood I; Fry H; Kartsonaki C; Mazidi M; Chen Y; Bragg F; Liu B; Yang L; Liu J; Avery D; Schmidt D; Sun D; Pei P; Lv J; Yu C; Hill M; Bennett D; Walters R; Li L; Clarke R; Du H; Chen Z;
    Diabetes Care; 2024 Jun; 47(6):1012-1019. PubMed ID: 38623619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
    Xiao J; Persson AP; Engström G; Johnson LSB
    BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
    Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
    Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
    Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
    Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of N-terminal pro B-type natriuretic peptide (NT-proBNP) change with the risk of atrial fibrillation in the ARIC cohort.
    Li L; Selvin E; Lutsey PL; Hoogeveen RC; O'Neal WT; Soliman EZ; Chen LY; Alonso A
    Am Heart J; 2018 Oct; 204():119-127. PubMed ID: 30099337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of Causal Effect of Atrial Fibrillation on Alzheimer Disease: A Mendelian Randomization Study.
    Pan Y; Wang Y; Wang Y
    J Am Heart Assoc; 2020 Jan; 9(2):e014889. PubMed ID: 31914880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
    Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
    Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic Mendelian randomization to identify protein biomarkers of telomere length.
    Zhao J; Yang K; Lu Y; Zhou L; Fu H; Feng J; Wu J
    Sci Rep; 2024 Sep; 14(1):21594. PubMed ID: 39284832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Evidence for Causal Association Between Atrial Fibrillation and Dementia: A Mendelian Randomization Study.
    Li M; Jiang C; Lai Y; Wang Y; Zhao M; Li S; Peng X; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Ma C
    J Am Heart Assoc; 2023 Aug; 12(16):e029623. PubMed ID: 37548160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study.
    Chen M; Ding N; Mok Y; Mathews L; Hoogeveen RC; Ballantyne CM; Chen LY; Coresh J; Matsushita K
    Clin Chem; 2022 Jul; 68(8):1084-1093. PubMed ID: 35762561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.